two (TWOA.U) announced the pricing of their $200 million IPO this morning and the shares are expected to begin trading on the NYSE under the symbol “TWOA”, Tuesday, March 30.
The new company intends to combine with a target advancing innovation and the democratization of technology with promising growth. two is led by co-founders and Co-CEOs Kevin Hartz and Gautam Gupta, alongside co-founder and CFO Troy B. Steckenrider III and Chairman Pierre Lamond.
Total SPAC deal count for 2021 year-to-date is now 297. The offering is anticipated to close on Thursday, April 1.
Citigroup Global Markets Inc. is serving as the sole book-running manager for the offering. Cadwalader, Wickersham & Taft LLP served as Issuer’s Counsel while Shearman & Sterling LLP served as Underwriter’s Counsel. WithumSmith+Brown, PC, acted as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...